Table 2: Baseline and at regimen change of clinical and immunological characteristics of patients on follow up at NGH from 2006 to 2016.

Characteristics Variable Baseline
n(%)
At Regimen Change
n (%)
Weight (kg) <45 43 (36.8%) 31 (26.5%)
46-60 41 (35%) 50 (42.7%)
>60 33 (28.2%) 36 (30.8%)
Functional status working 75 (64.1%) 101 (86.3%)
Ambulatory 35 (29.9%) 10 (8.6%)
Bed ridden 7 (6%) 6 (5.1%)
CD4 count (Cells/mm3) <50 8 (6.8%) 6 (5.1%0
50-200 48 (41.1%) 25 (21.4%)
200-350 52 (44.4%) 30 (25.6%)
350-500 9 (7.7%) 13 (11.1%)
>500 - 29 (24.8%)
Refused - 3 (2.6%)
Machine problem - 11 (9.4%)
WHO clinical stage I 21 (17.9%) 39 (33.3%)
- II 25 (21.4%) 34(29.1%)
- III 63 (53.9%) 41 (35.0%)
- IV 8(6.8%) 3 (2.6%)